FM

Fredrik P. Marmsater

AB Array Biopharma: 13 patents #53 of 335Top 20%
EL Eli Lilly: 5 patents #670 of 2,858Top 25%
Overall (All Time): #250,745 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12171739 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases Joseph P. Lyssikatos, Julie Marie Hicks, Qian Zhao 2024-12-24
10780073 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases Joseph P. Lyssikatos, Julie Marie Hicks, Qian Zhao 2020-09-22
10669269 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more 2020-06-02
9809590 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more 2017-11-07
9693989 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases Joseph P. Lyssikatos, Julie Marie Hicks, Qian Zhao 2017-07-04
9174981 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more 2015-11-03
8987251 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Hicks +13 more 2015-03-24
8895550 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Robert Kirk DeLisle, Julie Marie Hicks, Erik James Hicken, Joseph P. Lyssikatos +3 more 2014-11-25
8841455 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Mark Laurence Boys, Michael Bradley, Robert Kirk DeLisle, D. David Hennings, April L. Kennedy +7 more 2014-09-23
8648087 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases Joseph P. Lyssikatos, Julie Marie Greschuk, Qian Zhao, D. David Hennings, Weidong Liu 2014-02-11
8575145 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Greschuk +13 more 2013-11-05
8557809 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Robert Kirk DeLisle, Julie Marie Greschuk, Erik James Hicken, Joseph P. Lyssikatos +3 more 2013-10-15
8138181 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors Shelley Allen, Julie Marie Greschuk, Nicholas C. Kallan, Mark Munson, James P. Rizzi +5 more 2012-03-20
7858646 Potentiators of glutamate receptors Thomas D. Aicher, Dana Rae Benesh, Maria Jesus Blanco-Pillado, Guillermo S. Cortez, Todd Michael Groendyke +4 more 2010-12-28
7816523 Potentiators of glutamate receptors Thomas D. Aicher, Guillermo S. Cortez, Todd Michael Groendyke, Albert Khilevich, James Allen Knobelsdorf +2 more 2010-10-19
7803938 Potentiators of glutamate receptors Thomas D. Aicher, Guillermo S. Cortez, Todd Micheal Groendyke, Albert Khilevich, James Allen Knobelsdorf +2 more 2010-09-28
7678794 Potentiators of glutamate receptors Thomas D. Aicher, Guillermo S. Cortez, Todd Michael Groendyke, Albert Khilevich, James Allen Knobelsdorf +2 more 2010-03-16
7598423 Potentiators of glutamate receptors Thomas D. Aicher, Guillermo S. Cortez, Todd Michael Groendyke, Albert Khilevich, James Allen Knobelsdorf +3 more 2009-10-06